Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-045-3 | CAS number: 91-16-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From November 2003 to 12 February 2004
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study was carried out in compliance with principles of GLP and according to OECD TG 429. The test is well described and raw test results are available.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
- Report date:
- 2004
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- The study was based on a design adopted by ICCVAM and ECETOC (technical report No. 78 Skin sensitization testing: methodological considerations, Brussels, Dec 1999. OECD guideline 429.
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Veratrole
- EC Number:
- 202-045-3
- EC Name:
- Veratrole
- Cas Number:
- 91-16-7
- Molecular formula:
- C8H10O2
- IUPAC Name:
- 1,2-dimethoxybenzene
- Test material form:
- other: liquid
- Details on test material:
- Name: Vératrole
CAS number: 91-16-7
Description: colorless liquid
Container: one smoked glass flask
Date of receipt: 7 Nov. 2003
Storage conditions: RT
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Janvier, Le Genest-Saint-Isle, France
- Age at study initiation: 9 weeks old
- Weight at study initiation: 21.6 ± 1.3 g
- Housing: individually in disposable crystal polystyrene cages (22x8.5x8 cm)
- Diet (e.g. ad libitum): free access to A04 C pelleted dieet
- Water (e.g. ad libitum):free access to tap water (contained in bottles)
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22± 2∙C
- Humidity (%): 30-70%
- Air changes (per hr): 12 cycles/hours of filtered, non-recylced air
- Photoperiod (hrs dark / hrs light):12/12 h
IN-LIFE DATES: From: To: from 12 to 25 November 2003
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Remarks:
- batch N°I049312232 (Merck, Schelles, France) and olive oil, batch N°102K6001 (Sigma Saint-Quentin-Fallavier, France)
- Concentration:
- Preliminary test: 10-25-50-100% Vératrole
Main test: 5-10-25-50-100% Vératrole - No. of animals per dose:
- 8 females for the preliminary test (2 per concentration); 28 females for the main test (4 per concentration).
- Details on study design:
- RANGE FINDING TESTS:
- compound solubility: the test item was soluble in acetone/olive oil (4/1 v/v) (recommended vehicle). A homogeneous dosage form preparation was obtained at all concentrations.
- Irritation: on days 1,2 and 3 (before application) as well as on day 6 (after sacrifice), the thickness of the left ear of each animal of group 1 to 6 was measured using a micrometer. No measurement of ear thickness was performed for the animals of positive control group. Any irritation reaction (erythema and oedema) was recorded in parallel. Any other observation (coloration, presence of residual test item,...) was noted. Non irritant effect observed.
- Lymph node proliferation response: no increased lymph node proliferation
MAIN STUDY
ANIMAL ASSIGNEMENT AND TREATMENT
- Name of test method: Murine local lymph node assay (LLNA)
- Criteria used to consider a positive response: The test item was considererd as a skin sensitizer when the stimulation index (SI) for a dose group is > or equal to 3.
TREATMENT PREPARATION AND ADMINISTRATION: On days 1, 2 and 3 a volume of 25 uL using an adjustable pipette fitted with a plastic tip of the control or dosage was applied to the dorsal surface of both ears. Animals were slightly anaesthesized with isoflurane during application to avoid licking and ensure optimal application of the test material. No massage was performed but the tip was used to spread the preparation over the application sites. No rinsing was performed between each application.
On day 6, all animals recieved a single intravenous injection of 250 uL of 0.9% NaCl containing 20 uCi of 3H-TDR (specific acitivity of 25 Ci/mmol) via the tail vein. Approx. 5 hours later, the animals were killed by cervical dislocation and the auricular lymph nodes were excised. The lymph nodes were pooled for each experimental group.
For each experimental group, a single cell suspension of auricular lymph node cells (ALNC) was prepared by mechanical dissagregation in Petri dishes with the plunger of a syringe. Cell suspensions were washed with 15 mL of 0.9% NaCl and pellets obtained were re-suspended in 0.9% NaCl for numeration of lymphocytes (cellularity) and determination of their viability by exclusion of trypan blue. Each cell suspension was then centrifuged and pellets were precipitated with 3 mL of 5% (w/v) trichloroacetic acid (TCA) in purified water at +4°C overnight. After a last centrifugation, the pellets were precipitated with 1 mL of 5% TCA. Three mL of Ultima GoldxR scintillation fluid (Packard) were added in order to measure incorporation of 3H-TdR using β-scintillation counting.
The results were expressed as disintegration's/mn (dpm) per group.
Stimulation Indices (SI) were calculated according to the following formula:
SI =dpm of treated group /dpm of control group
The stimulation index (SI) is expressed as the disintegrations per minute (dpm) in the treated groups divided by the disintegrations per minute (dpm) in the control group. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- not performed
Results and discussion
- Positive control results:
- In the positive control group given HCA at the concentration of 25%, a moderate increase in cellularity and a stimulation index (SI) exceeding the threshold value of 3 (SI=10.78) were noted. The study was therefore considered as valid.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Value:
- 2.03
- Test group / Remarks:
- Veratrole 5%
- Parameter:
- SI
- Value:
- 1.18
- Test group / Remarks:
- Veratrole 10%
- Parameter:
- SI
- Value:
- 1.31
- Test group / Remarks:
- Veratrole 25%
- Parameter:
- SI
- Value:
- 1
- Test group / Remarks:
- Veratrole 50%
- Parameter:
- SI
- Value:
- 1.7
- Test group / Remarks:
- Veratrole 100%
- Parameter:
- SI
- Value:
- 10.78
- Test group / Remarks:
- Positive control: HCA
Any other information on results incl. tables
Table 7.4.1/2: Results of the main study
Groups |
Treatment and concentrations |
Cell count |
viability (%) |
Number of nodes per gp |
dpm per group |
dpm per node |
Stimulation index (SI) |
increase in ear thickness (% between day 1 and 6) |
Irritation classe |
EC3 value |
|
1 |
Acetone/olive oil 0% |
106 |
10 |
91,38 |
8 |
562,51 |
70,31 |
|
7,29 |
|
NA |
2 |
Veratrole 5% |
228 |
16 |
93,44 |
8 |
1140,05 |
142,51 |
2,03 |
4,17 |
I : non-irritant |
|
3 |
Veratrole 10% |
133 |
17 |
88,67 |
8 |
660,97 |
82,62 |
1,18 |
3,06 |
||
4 |
Veratrole 25% |
113 |
19 |
85,61 |
8 |
738,05 |
92,26 |
1,31 |
7,45 |
||
5 |
Veratrole 50% |
126 |
16 |
88,73 |
8 |
564,84 |
70,61 |
1.00 |
10,64 |
||
6 |
Veratrole 100% |
123 |
21 |
85,42 |
6 |
718,34 |
119,72 |
1.70 |
4.30 |
||
7 |
HCA 25% |
199 |
28 |
87,67 |
8 |
6.061 |
757,65 |
10,78 |
|
|
dpm = disintegrations per minute
viability = (viable cells)/(viable cells + dead cells)
cellularity index= amount of cells (*10^6 cells) in the treated group/amount of cells (*10^6 cells) in the vehicle group
stimulation index = dpm of treated group/dpm of control group
EC3 value = theoretical concentration resulting in a SI value of 3
NA= not applicable
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the experimental conditions, the test item Vératrole does not induce delayed contact hypersensitivity in the murine local lymph node assay.
- Executive summary:
The aim of the study (2004) was to evaluate the potential of the test item Veratrole to induce delayed contact hypersensitivity using the murine local lymph node assay (LLNA), according to the OECD guideline 429 and under GLP conditions.
A preliminary test was first performed in order to define the concentrations of test item to be used in the main test.
In the main test, twenty-eight female CBA/J mice were allocated to seven groups:
• five treated groups of four animals receiving the test item Vératrole at the concentration of 5, 10, 25, 50 or 100%,
• one negative control group of four animals receiving the vehicle (mixture acetone/olive oil (4/1)),
• one positive control group of four animals receiving the reference item, α-hexylcinnamaldehyde (HCA), a moderate sensitizer, at the concentration of 25%.
During the induction phase, the test item, vehicle or reference item was applied over the ears (25 μL per ear) for three consecutive days (days 1, 2 and 3). After 2 days of resting, the proliferation of lymphocytes in the lymph node draining the application site was measured by incorporation of tritiated methyl thymidine (day 6). The obtained values were used to calculate stimulation indices (SI).
The irritant potential of the test item was assessed in parallel by measurement of ear thickness on days 1, 2, 3 and 6.
The test item was soluble in the first recommended vehicle, acetone/olive oil (4/1, v/v). A homogeneous dosage form preparation was obtained whatever the proportion. Consequently, the concentrations selected for the main test were 5, 10, 25, 50 and 100%.
No mortality related to treatment and no clinical signs were observed during the study.
No cutaneous reactions were observed during the study.
Except for a very slight increase in ear thickness recorded at the concentration of 50%, no noteworthy increase in ear thickness was observed in the treated groups.
No noteworthy lymphoproliferation was noted at any tested concentration, while significant lymphoproliferation was observed with HCA at 25%.
Under these experimental conditions, the test item Veratrole does not induce delayed contact hypersensitivity in the murine Local Lymph Node Assay and it is not classified as a skin sensitizer according to the regulation (EC) 1272/2008 (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.